A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer

Clinical trial NCT02042885 · TERMINATED

Trial details

NCT number: NCT02042885
Sponsor: Otsuka Novel Products GmbH
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Salivary Gland Cancer Endometrial Cancer Squamous Cell Carcinoma of the Cervix Breast Cancer Ovarian Cancer

Start date: 2014-01-01
Primary completion: 2015-02-01
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.